Juwaria Waheed, MD

Scientific Reviewer
FDA/CDER/OND/OTBB (Office of Therapeutic Biologics and Biosimilars)
Silver Spring, MD

Disclosure information not submitted.

Presentation(s):

• (R2) Biosimilar Operational Readiness: Marketplace Trends and Regulatory Considerations

  Tuesday, October 17, 2023
  10:15 AM – 11:30 AM East Coast USA Time